Results 221 to 230 of about 257,686 (307)

CANCER IN THE THORACIC STOMACH

Journal of Thoracic Surgery, 1955
openaire   +2 more sources

Adipocyte‐Derived Leptolin Enhances Energy Expenditure and Prevents Obesity

Advanced Science, EarlyView.
We identified a novel adipokine, which we named leptolin. In humans, leptolin levels in white adipose tissue were positively correlated with exercise and negatively associated with body mass index. We observed elevated leptolin in serum from athletes and lower leptolin in serum from obese individuals.
Jiarui Liu, Bingwei Wang, Zhijie Su, Xiaoxv Han, Miao He, Yun Zhao, Yujia Hou, Daotong Li, Weiguang Zhang, Lihua Qin, Ke Wang, Yanchun Li, Yi Yan, Siwang Yu, Xiaoshuai Huang, Tairan Yuwen, Jianyuan Luo, Ruimao Zheng   +17 more
wiley   +1 more source

Dietary protein intake and stomach cancer, insights from a case-control study. [PDF]

Sci Rep
Le NT, Van Nguyen T, Le LT, Nguyen LC.
europepmc   +1 more source

Chemotherapy in cancer of the stomach

Journal of British Surgery, 1966
B J, Wilken, J W, Thomson
openaire   +2 more sources

PRMT1‐Mediated LDHA Methylation Drives STAT3 Lactylation to Orchestrate Intestinal Inflammation and Tumorigenesis

Advanced Science, EarlyView.
This study identifies an immunometabolic axis wherein SAM‐driven PRMT1 methylates LDHA, enhancing its activity. The resultant lactate induces STAT3 K709 lactylation, which stabilizes an active conformation to promote STAT3 phosphorylation and IL‐10 expression.
Hui Wang, Mengyu Zhang, Weipeng Gong, Jiaxuan Wu, Junping Zhang, Wenxiu Zhang, Yue Liu, Kui Wang, Canhua Huang, Jun Zhou, Sijin Wu, Yan Li, Tianliang Li   +12 more
wiley   +1 more source

Stomach cancer elective surgery morbidity and mortality at 90-Day (Hold Study): a prospective, international collaborative cohort study. [PDF]

Langenbecks Arch Surg
Neves-Marques C, Abulazayem M, Wong GYM, Maldonado RD, Viswanath Y, Boddy A, Donohoe C, Scarano JP, Martinino A, Aamery A, Abdulkhakimov N, Abuobaida EE, Aday U, Al-Shami K, Alhajami F, Almeida A, Almoshantaf MB, Ahmed H, Andrada M, Anwer AW, Awad AK, Baili E, Baraket O, Barbosa J, Baker C, Bakri A, Boras Z, Caiado A, Cayirci C, Calini G, Cianci P, Cinal E, Chouliaras C, Colak E, Correia MT, Costeira B, Davletshina V, D'Acapito F, Donmez T, Drozdov E, Ercolani G, Erdene S, Erginöz E, Ferreira SR, Fragoso M, Framarini M, Galandarova A, Genser L, Gorohov I, Grosek J, Guerrero S, Hasırcı I, Ibrahimli A, Ithurralde-Argerich J, Karabulut M, Kinoshita T, Khalid IB, Khan K, Khattak S, Khomyakov V, Krawczyk W, Khamees A, Kostrygin A, Košir J, Lorenc Z, Milhomem J, Marom G, Melo A, Menasria A, Meric S, Mulita F, Muratore A, Omarov T, Palomba G, Paul N, Pathak A, Pavone G, Pavlov R, Pinillla R, Rasheed O, Remini A, Ryabov A, Samadov E, Samarasam I, Sandag E, Santos J, Sanchez E, Saroglu A, Schizas D, Serralheiro PA, Simsek O, Sobolev D, Souadka A, de Sousa JV, Sousa F, Suer M, Surendran S, Syllaios A, Syed AA, Terajima D, Tokocin M, Triantafyllou T, Uludağ S, Uprak T, Vaz S, Vecchiato M, Verras GI, Veroux M, Voon K, Vovin K, Yacob M, Walędziak M, Zacharenko A, Zahara FT, Singhal R, Mahawar K, HOLD Study Collaborative Group.   +116 more
europepmc   +1 more source

ZDHHC9‐Mediated Palmitoylation of ACSL4 Drives Ferroptosis in Diabetes Mellitus–Induced Erectile Dysfunction

Advanced Science, EarlyView.
ABSTRACT Diabetes mellitus‐induced erectile dysfunction (DMED) is a highly prevalent complication among diabetic patients; however, its underlying pathogenic mechanisms remain incompletely understood. Metabolic disorder is a hallmark of diabetes, yet its precise contribution to DMED progression is not well defined.
Wanyang Guo, Ming Xiao, Mengjun Huang, Dongzi Peng, Ruijiang Zeng, Ruilin Liu, Yuanqiao Zhao, Zhihan Ouyang, Yulong Hong, Zexian Ding, Zhuo Xing, Hao Su, Jinxiang Wang, Wenjun Mao, Xin Jin   +14 more
wiley   +1 more source

Circadian sleep-wake rhythm reversal in mice implanted with stomach cancer cell lines. [PDF]

J Physiol Sci
Goto M, Maruyama T, Nonaka M, Uezono Y, Ueta Y, Ueno S.   +5 more
europepmc   +1 more source

A Radioresistant‐Tumor‐Targeted Nanoparticle for X‐Ray‐Controlled Nitric Oxide Release to Potentiate Radiotherapy

Advanced Science, EarlyView.
The PBTN targets GRP78 and, upon X‐ray irradiation, generates ONOO− to induce immunogenic cell death, thereby activating CD8+ T cells and establishing a systemic antitumor immune response. ABSTRACT Nitric oxide (NO) treated radioresistant tumors by relieving hypoxia and blocking DNA repair, but its nonselective toxicity has precluded therapeutic use ...
Wanze Zhang, Xiaoyan Yin, Ting Wang, Hongfu Zhao, Zhipeng Zhao, Jinbao Wang, Cheng Tao, Xuanchu Ge, Yanze Li, Linlin Liu, Fuxin Xue   +10 more
wiley   +1 more source

The AUTACE That Degrades KRAS and Engages CD8+ T Cells for the Treatment of KRAS/TP53 Co‐Mutant Tumors

Advanced Science, EarlyView.
AUTACE is a bifunctional nanoplatform that integrates tumor targeting, immune engagement, and on‐demand KRAS degradation. It targets KRAS/TP53 co‐mutant tumors via TP53‐specific TCRs, elicits antitumor CD8+ T‐cell responses through surface anti‐CD3 antibodies, and uses low‐intensity focused ultrasound (LIFU) to trigger controlled release of the KRAS ...
Luo Li, Bolin Li, Yanan Hao, Bo Pang, Pan Li, Chunli Li, Yu Tang   +6 more
wiley   +1 more source